Objectives. The purpose of the study was to assess quality of life (QoL) among patients with epilepsy and to analyze the effect and significance of selected clinical and social factors on their QoL level. QoL became an important measure of patients' health status, even though it is not always concordant with clinical criteria of health status evaluation. QoL assessment can be regarded as pertaining to a dynamic process, and not to a stable outcome.
Method. QoL was assessed using the international questionnaire QOLIE-31. Participants in the study were 66 epileptic patients (35-M, 31-F) aged 20 to 70 years, suffering from epilepsy for at least 3 years. Besides the QOLIE-31 questionnaire they filled out also the Beck Depression Inventory (BDI). A physician evaluated their cognitive processes using the MMSE, and filled out a special questionnaire concerning the patient's socio-demographic status and medical history.
Results. The mean QOLIE-31 score in the group under study was 61.0, closely approximating that obtained in the American standariza-tion procedure (62.87). However, our patients' scores were much higher than these in a group of 106 Polish patients in Gdańsk (44.73). Neither gender, nor clinical (age, disease duration, frequency of seizures) and social (marital status) factors had a significant effect on the patients' QoL. However, considerable differences in QoL were found between patient groups with different severity of depressive symptoms measured using the BDI. The higher the BDI score, the poorer was the patients' quality of life assessed with QOLIE-3. The relationship was statistically significant.